Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study

被引:2
|
作者
Foster, Katherine, I [1 ]
Handley, Katelyn F. [1 ,2 ,3 ]
Glassman, Deanna [1 ]
Sims, Travis T. [1 ]
Javadi, Sanaz [4 ]
Palmquist, Sarah M. [5 ]
Saleh, Mohammed M. [5 ,6 ]
Fellman, Bryan M. [7 ]
Fleming, Nicole D. [1 ]
Bhosale, Priya R. [5 ]
Sood, Anil K. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[2] Univ S Florida, Div Gynecol Oncol, Morsani Coll Med, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol Body Imaging, Houston, TX USA
[5] Univ Texas MD Anderson Canc Ctr, Abdominal Imaging Dept, Houston, TX USA
[6] Univ Calif San Diego, Dept Radiol, San Diego, CA USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
基金
美国国家卫生研究院;
关键词
Ovarian Cancer; Cystadenocarcinoma; Serous; HETEROGENEITY; RESISTANCE; SURVIVAL; TUMOR;
D O I
10.1136/ijgc-2022-004206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveA novel classification system of high-grade serous ovarian carcinoma based on gross morphology observed at pre-treatment laparoscopy was recently defined. The purpose of this study was to identify radiographic features unique to each morphologic subtype. MethodsThis retrospective study included 109 patients with high-grade serous ovarian cancer who underwent pre-operative computed tomography (CT) scanning and laparoscopic assessment of disease burden between 1 April 2013 and 5 August 2015. Gross morphologic subtype had been previously assigned by laparoscopy. Two radiologists independently reviewed CT images for each patient, categorized disease at eight anatomic sites, and assessed for radiographic characteristics of interest: large infiltrative plaques, mass-like metastases, enhancing peritoneal lining, architectural distortion, fat stranding, calcifications, and lymph node involvement. Demographic and clinical information was summarized with descriptive statistics and compared using Student's t-tests, chi(2) tests, or Fisher exact tests as appropriate; kappa statistics were used to assess inter-reader agreement. ResultsCertain radiographic features were found to be associated with gross morphologic subtype. Large infiltrative plaques were more common in type 1 disease (88.7% (47/53) vs 71.4% (25/35), p=0.04), while mass-like metastases were more often present in type 2 disease (48.6% (17/35) vs 22.6% (12/53), p=0.01). Additionally, radiographic presence of disease at the falciform ligament was more common in type 1 morphology (33.9% (19/56) vs 13.2% (5/38), p=0.02). ConclusionMorphologic subtypes of high-grade serous ovarian cancer were associated with specific CT findings, including the presence of large infiltrative plaques, mass-like metastases, and falciform ligament involvement.
引用
收藏
页码:937 / 943
页数:7
相关论文
共 50 条
  • [41] Dynamic of molecular subtypes of high-grade serous ovarian cancer in paired primary and relapsed biopsies.
    Braicu, Elena Ioana
    Kulbe, Hagen
    Dreher, Felix
    Taube, Eliane T.
    Ringel, Frauke
    Welsch, Gabriele
    Darb-Esfahani, Silvia
    Keunecke, Carlotta
    Kessler, Thomas
    Wierling, Christoph
    Jank, Paul
    Denkert, Carsten
    Lammert, Hedwig
    Hummel, Michael
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [43] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [44] Tumor immunogenicity status in high-grade serous ovarian cancer
    Berry, Laurel
    Kelly, Michael
    Miller, Lance
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S319 - S319
  • [45] Novel strategies for targeting high-grade serous ovarian cancer
    Perets, Ruth
    Wyant, Gregory A.
    Ohman, Anders W.
    Setlur, Sunita R.
    Crum, Christopher P.
    Drapkin, Ronny
    Dinulescu, Daniela M.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [46] Describing intratumoural heterogeneity in high-grade serous ovarian cancer
    Nixon, K.
    Wulandari, R.
    Curry, E.
    Rama, N.
    Bowtell, D.
    Cunnea, P.
    Fotopoulou, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 87 - 88
  • [47] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [48] Principles of dormancy evident in high-grade serous ovarian cancer
    Shepherd, Trevor G.
    Dick, Frederick A.
    CELL DIVISION, 2022, 17 (01)
  • [49] Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous Ovarian Cancer: A Hypothesis-generating Study
    Vargas, Hebert Alberto
    Micco, Maura
    Hong, Seong Im
    Goldman, Debra A.
    Dao, Fanny
    Weigelt, Britta
    Soslow, Robert A.
    Hricak, Hedvig
    Levine, Douglas A.
    Sala, Evis
    RADIOLOGY, 2015, 274 (03) : 742 - 751
  • [50] Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study
    Pang, Li
    Guo, Zhiqiang
    FRONTIERS IN ONCOLOGY, 2022, 12